Vaccine hesitancy is a significant concern in mitigating COVID-19. A study across seven European nations and the US showed that 26% of European adults indicated hesitance or resistance to a COVID-19 vaccine and that number increased to 33% in the US. How can we reach the vaccine hesitant to support COVID-19 vaccination and what can we do to address the concerns of these communities and individuals? Avril Lee, Head of Healthcare Europe at Zeno Group and Chair of the CIPR’s Diversity and Inclusion Network discusses approaches and communications priorities on bringing people closer to supporting COVID-19 vaccination.
The US is promising 100 million people vaccinated in 100 days; the UK is aiming for 36 million by August while France is looking at 70 million by the end of August. Lofty goals at a time when even distributing the vaccines is a logistical challenge. But perhaps the biggest challenge is getting people to have the vaccine at all. Consider the measles outbreak of 2019 in the US. In 2000, the Centers for Disease Control (CDC) deemed measles eradicated as an endemic disease in the US, but in 2019, an outbreak created a public health threat that medical experts say could have been avoided if parents had not declined to give their children a safe and reliable vaccine. Named one of the 10 greatest health threats of 2019 by the World Health Organization, “vaccine hesitancy” was cited as a causal factor in the measles outbreaks.
Vaccine hesitancy is a significant concern in mitigating COVID-19. A study across seven European nations and the US showed that 26% of European adults indicated hesitance or resistance to a COVID-19 vaccine and that number increased to 33% in the US. And while recent UK experience suggests the recent communications on the threat of Corona virus can change perceptions with the UK public demonstrating very high confidence in the COVID-19 vaccines, 90%+ of those vaccinated so far are white. Across countries, the communities disproportionately impacted by COVID-19 are the same communities that, due to long standing social and health disparities, have a deep distrust of Government and the systems administering and communicating about the vaccine.
The high level of distrust among those that report vaccine hesitancy for those who represent authority may only deepen resistance to messages encouraging vaccination. Vaccine hesitant individuals may be more receptive to messages regarding COVID-19 vaccine safety and efficacy if they are delivered by individuals within non-traditional positions of authority and expertise. Key to this effort is a multi-disciplinary approach engaging social and behavioral change communication experts, social marketers, medical anthropologists, psychologists, and health care practitioners.
Reaching the vaccine hesitant to support COVID-19 vaccination
Many are quick to cast those individuals who are hesitant as misinformed, naïve, or worse, conspiracy theorists. Yet, concerns in a pandemic are natural and a more thoughtful consideration of drivers of issues can go a long way toward bringing people closer to acceptance. Critical here is to understand the difference between those who are ‘hesitant’ and those who are ‘refusers’ as this should inform both approaches and communication priorities. Some approaches to closing the hesitancy gap:
In short, addressing concerns about the value and safety of vaccines requires a focus on both rational and emotional appeals. Engaging communities and individuals in authentic, community specific conversations about health concerns should be the first step in overcoming anxiety and mistrust.
Author
Avril Lee is Head of Healthcare Europe at Zeno Group and Chair of the CIPR’s Diversity and Inclusion Network. To find out how we can help with your communications needs email hello@3monkeyszeno.com
Address:
3 Monkeys Zeno
THE LIGHTBOX
127-133 Charing Cross Road
London
WC2H 0EW
United Kingdom